Friday, 29 March 2024
American Learning Corp New Yor
14:18 | 22/2/18
StockNewsTimes
Wall Street brokerages forecast that Aileron Therapeutics Inc (NASDAQ:ALRN) will announce earnings per share (EPS) of ($0.46) for the current quarter, Zacks reports.
more»
09:48 | 22/2/18
BZ Weekly
The stock increased 2.21% or $0.17 during the last trading session, reaching $7.86. About 4,192 shares traded. Aileron Therapeutics, Inc. (NASDAQ:ALRN) has 0.00% since February 21, 2017 and is . It has underperformed by 16.70% the S&P500. Aileron ...
more»
23:18 | 21/2/18
Frisco Fastball
More notable recent Aileron Therapeutics, Inc. (NASDAQ:ALRN) news were published by: Businesswire.com which released: “Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its …” on October 29, 2014, also Seekingalpha.
more»
23:18 | 21/2/18
Frisco Fastball
More notable recent Aileron Therapeutics, Inc. (NASDAQ:ALRN) news were published by: Globenewswire.com which released: “Aileron Therapeutics Announces Pricing of Initial Public Offering” on June 29, 2017, also Businesswire.
more»
10:45 | 15/2/18
Aiken Advocate
Investors who prepare themselves for any scenario should be in a much better place than those who don't. Active traders may be zooming in on some additional technical indicators for share assessment.
more»
09:37 | 15/2/18
FLBC News
Shares of Aileron Therapeutics Inc (ALRN) are moving on volatility today -0.96% or $-0.08 from the open. The NASDAQ listed company saw a recent bid of $8.22 and 845 shares have traded hands in the session.
more»
04:11 | 14/2/18
Stock Press Daily
Traders and investors may be taking note of Aileron Therapeutics Inc (ALRN) shares and how they are expected to move mid-term.
more»
10:22 | 13/2/18
Aiken Advocate
Shares of Aileron Therapeutics Inc (ALRN) are moving on volatility today -1.90% or $-0.15 from the open. The NASDAQ listed company saw a recent bid of $7.725 and 14801 shares have traded hands in the session.
more»
10:52 | 10/2/18
BZ Weekly
More notable recent Aileron Therapeutics, Inc. (NASDAQ:ALRN) news were published by: Globenewswire.com which released: “Aileron Therapeutics Announces Oral Presentations on Lead Product Candidate …” on November 01, 2017, also Globenewswire.
more»
18:26 | 8/2/18
StockNewsTimes
Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Aileron Therapeutics earned a news impact score of 0.10 on Accern's scale. Accern also gave press coverage about the company ...
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |